Boston Chapter of the International Association of Clinical Research Nurses. Clinical Research Nursing, Nursing, Patients/participants healthcare, science.
May 20 annually is Clinical Trials Day. IACRN joins CRNs in celebrating! Together we can is the theme of Clinical Trials Day 2023. Download this frame, share your passion for your work, and share on social media! thanks @ACRPDC for the #CTD2023 graphics. #ClinicalTrialsDay
Wonderful talk on Leadership in Clinical Research Nursing by Ruth Endacott, shift in NINR from “underrepresented” to “underserved” in participant populations @iacrn#iacrn22
If you want something fixed right...get a nurse! That's what @CDCgov is doing. Meet the 'change agent' responsible for revamping the agency amp-cnn-com.cdn.ampproject.o…
Join us in-person on October 17-19, 2022 in Atlanta, GA for the 2022 IACRN 14th Annual Conference: Advancements in Clinical Research Nursing: Building Practice Excellence! Only 3 weeks left to register iacrn.org/2022-conference@IACRNUKandIRE@BostonIacrn#iLoveIACRN
We are two months into an outbreak of monkeypox across the world and I find it incredibly frustrating that we seem to be stuck on debating whether this virus is really overwhelmingly affecting MSM (and whether it is homophobic to point that out) or whether to call this an STD.
****Twitter Chat alert**** Please join us on July 19th for a Twitter Chat on #CRNurse & #CRMidwife leadership & to find out more about the IACRN Leadership Program. The timings will be:
10:00 PDT
13:00 EDT
18:00 Ireland & UK
19:00 CET & South Africa
Today 2/21/22 marks the 2-year anniversary of the very first patient enrolled in ACTT trial➡️Adaptive #COVID19 Treatment Trial
CONGRATULATIONS to the ACTT Network for successfully completing 4 double-blind placebo-controlled randomized trials and discovering 2 new therapies!
🧵1/
The "History of HIV" talk I gave last week actually has this title, which I don't think is an overstatement. Posting it now with gratitude, just in time for Thanksgiving (my favorite holiday -- the gratitude and family part).
(Part 1 thread)
1/x
Today, the ACTG announced the graduation of the novel polyclonal antibody therapy, SAB-185 to the phase 3 study of ACTIV-2. Read more at the link below!
actgnetwork.org/2021/09/27/a…